Company Overview and News

11
Funding for U.S. Fintech Startups Rose 40 Percent Last Quarter - Bloomberg

2018-07-12 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
JBK SQ SQNXF GS.PRICL GSC TFG GS.PRB GS.PRA PYPL GSJ GS.PRJ GS.PRI GS GLSSP GS.PRD GS.PRC GJS GS.PRN GS.PRK

8
Shopify Cozies Up to Google Again With Plan to Sell Nest Cameras - Bloomberg

2018-07-12 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
SQ SHOP SQNXF GOOGL GOOG

5
Should You Invest in the Global X FinTech ETF (FINX)?

2018-07-12 zacks
If you're interested in broad exposure to the Technology - Broad segment of the U.S. equity market, look no further than the Global X FinTech ETF (FINX - Free Report) , a passively managed exchange traded fund launched on 09/12/2016.
WCAGY SQ SQNXF FENY FDIS WRCDF

31
Even at All-Time Highs, Facebook Stock Has More Juice Left

2018-07-12 investorplace
Facebook, Inc. (NASDAQ:FB) has quieted its doubters — at least for now. Facebook stock reached another all-time closing high on Monday, finishing just south of $205. The stock now has gained 15% so far this year — an improvement that seemed unlikely just a few months ago.
WFC WFCNP WFC.WS FB SQ SQNXF WFC.PRL NFLX WFC.PRJ WFC.PRT WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN TWTR KO WFC.PRY WFC.PRX WFC.PRW WFC.PRV SNAP

83
PayPal Holdings Inc. Has the Smell of Musk in Payments

2018-07-10 investorplace
Here’s an interesting piece of trivia: Elon Musk did not found Tesla. But he did co-found the company that later became Paypal Holdings Inc. (NASDAQ:PYPL).
GE V GEC SQ SQNXF WP TSLA GNE PYPL SYF EBAY

13
Trade of the Day: Square Inc (SQ) | InvestorPlace

2018-07-09 investorplace
To receive further updates on this Square Inc (NYSE:SQ) trade as well as an alert when it’s time to take profits, sign up for a risk-free trial of SlingShot Trader today.
SQ V SQNXF

18
Change Financial Appoints Industry Veteran Eric Bachman as CEO, Raises US$2.62M via Share Placement and Option to Acquire Ivy Entities

2018-07-09 accesswire
SYDNEY, AUSTRALIA and LOS ANGELES, CA / ACCESSWIRE / July 9, 2018 / Sydney, Australia and Los Angeles CA, U.S-based fintech, banking software, and blockchain investment company Change Financial Limited (ASX: CCA, OTCQX: CNGFF) ("Change Financial" or "the Company") is pleased to announce the appointment of a new CEO, the receipt of commitments to raise US$2.62M and that it has acquired a call option from Elmoson Pty Ltd ("Elmoson") to purchase the remaining 67% interests in Ivy Koin LLC (Delaware registered) and Ivy Blockchain Pty Ltd (the "Ivy Entities") that it does not currently own (the "Ivy Option").
WFC WFCNP WFC.WS DFS SQ CNGFF SQNXF WFC.PRL MA WFC.PRJ DFS.PRB WFC.PRT DFS.PRBCL WFC.PRR WFC.PRQ V WFC.PRP WFC.PRO WFC.PRN WFC.PRY WFC.PRX WFC.PRW WFC.PRV

5
Square Withdraws FDIC Application

2018-07-06 247wallst
Square Inc. (NYSE: SQ) announced late on Thursday that it would be withdrawing its application with the Federal Deposit Insurance Corporation (FDIC) for a banking charter. Although, the firm said that it plans to resubmit this at a later date.
FISI SQ SQNXF FIISO FIISP

5
Payments processor Square Inc. withdraws banking license application -statement

2018-07-05 reuters
WASHINGTON (Reuters) - San Francisco-based payments processor Square Inc. (SQ.N) said on Thursday it had withdrawn its regulatory application to open a deposit-taking bank, but that the company plans to refile its paperwork at a later date.
FISI SQ SQNXF FIISO FIISP

141
Square Stock Is So Hot It Won’t Be Long Before PayPal Strikes Back

2018-06-29 investorplace
Square Inc (NYSE:SQ) seems unstopple. For the year so far, the Square stock is up a sizzling 156%.
BAC INTU SQ SHOP JPM SQNXF WIX MA PYPL GDDY

18
Square stock downgraded at Stephens; analyst says he prefers PayPal - MarketWatch

2018-06-26 marketwatch
Shares of Square Inc. SQ, +1.31% are up 0.7% in Tuesday trading after Stephens analyst Brett Huff downgraded the stock to equal weight from overweight. Shares initially opened lower. "After a truly remarkable stock price acceleration over past two years and tougher comps coming," Huff thinks that the company's current share price is appropriate. "We think that the 13.5x forward adjusted revenue appropriately captures most of this value especially when compared with a high-value high-growth set of comps.
SQ SQNXF PYPL

18
PayPal launches debit card for its mobile app Venmo

2018-06-25 reuters
(Reuters) - PayPal Holdings Inc said on Monday it is launching a debit card for users of its mobile app Venmo in a bid to broaden its reach with younger users.
SQ SQNXF PYPL

708
Is This The Biggest Fintech Opportunity Of 2018?

2018-06-24 oilprice
Your license and viewing of our content is subject to the disclosures contained after this article.
TDC SQ SHOP WU SQNXF PVVTF AMD SH ABT ALSWF

39
Twitter short sellers double down, as Square shorts run for cover - MarketWatch

2018-06-21 marketwatch
Two Jack Dorsey companies, alike in their huge stock rallies, differ when it comes to recent short-selling sentiment.
SQ SQNXF TWTR

684
Serving The Unbanked: The Trillion Dollar Opportunity Banks Don’t See

2018-06-20 oilprice
Your license and viewing of our content is subject to the disclosures contained after this article.
TDC SQ WU SQNXF RPD DTK AMD

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...